SEC Form 4 · accession 0001104659-17-038900
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald K Stern
Director
Period of report
Jun 12, 2017
Accepted (ET)
Jun 13, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Jun 12, 2017 | P | 2,500 | $9.10 | A | 2,500 | D |
Table II — derivative securities
No Table II lines on this filing.